Heart and Circulatory Diseases (Covid-19)

Debate between Maggie Throup and Jim Shannon

Thursday 23rd June 2022 Commons Chamber

[Maggie Throup]

I think that question should be directed at the Treasury, not the Department of Health and Social Care.

If I may continue to address questions raised, I am pleased to say that our target of 50,000 more nurses is on track for 2024. My hon. Friend the Member for Meon Valley (Mrs Drummond) made the very good point that it takes quite some time to train our amazing healthcare professionals, particularly those who are highly specialised, such as in cardiology. She also highlighted the disparity in waiting times. In England, 11.6% of the population is on a waiting list, but in Labour-run Wales, as she rightly said, the figure is 21%. We have to be careful when we make comparisons and try to criticise one nation over another. Everybody is trying their utmost to get things back on track in whatever way they can, because we know that the population’s health is a priority.

[Jim Shannon]

One of the questions I asked, in a constructive manner, was about the shortage of 100 consultant cardiologists. I am mindful—this was referred to by another hon. Member—that that training can take 10 to 15 years. If the Minister does not have the answer today, I am happy for her to write to let us know.

[Maggie Throup]

The hon. Gentleman asks a specific question, so if I may, I will get back to him.

In conclusion, I hope today I have demonstrated the Government’s commitment to improve the lives of people living with heart and circulatory disease. Our commitment is there. If we can continue to make an impact on the lives of people with these conditions with better prevention, diagnostics and treatment, it will bring significant benefits to the NHS and better health outcomes for those affected. We can all agree that that really matters. Once again, I thank the hon. Member for Strangford for bringing this very important issue to the House for debate today.

Smokefree 2030

Debate between Maggie Throup and Jim Shannon

Tuesday 26th April 2022 Westminster Hall

[Maggie Throup]

If I may, I will come to that later in my speech, but the hon. Lady makes a very good point.

On top of the measures, the NHS has renewed its commitment to tobacco treatment through the NHS long-term plan, delivering NHS-funded tobacco treatment services to all in-patients, pregnant women and people accessing long-term mental health and learning disability services until 2024. The Government also continue to explore ways to move smokers away from smoking and towards alternative nicotine products such as vapes, as highlighted by the hon. Member for North Tyneside (Mary Glindon). We know that the best thing a smoker can do for their health is to quit smoking altogether, but we also know how hard that can be. It remains the Government’s goal to maximise the public health opportunities presented by vapes while ensuring that such products are not appealing to young people and non-smokers. The hon. Member for Denton and Reddish made a very good point on this issue in his speech, and it requires balanced and proportionate regulation.

Despite the progress made so far, the Government acknowledge that we need to go further to achieve our ambition to be smokefree by 2030, which is why the Secretary of State for Health and Social Care asked Javed Khan OBE to lead an independent review into tobacco control in January this year. The Khan review is expected to be published next month and will make a set of recommendations to the Government. The review has two objectives. The first is to identify the most impactful interventions to reduce the uptake of smoking, particularly among young people. The second is to identify how best to support smokers to quit, especially in deprived communities and among priority groups.

Mr Khan has met hon. Members from both the all-party parliamentary group on smoking and health and the all-party parliamentary group for vaping, and he has carefully considered their views and proposals. Quite a number of members of those APPGs have expressed their approval of that route and how Javed Khan is getting into the depth of everything. Once the review is published next month, the Government will consider its recommendations, which will help inform both the upcoming health disparities White Paper and the new tobacco control plan, to be published later this year.

[Jim Shannon]

I thank the Minister for her response to this issue, and what she is saying is very positive. I am ever mindful that Northern Ireland has the highest rate of deaths due to smoking. Health is a devolved matter, and we are 10 years behind the rest of the UK on achieving our goals. What discussions could the Minister have with the Northern Ireland Assembly, and particularly with the Health Minister, Robin Swann, to enable us to catch up and achieve the goals and targets that the Minister has referred to?

[Maggie Throup]

The hon. Gentleman makes a very good point. The hon. Member for Arfon (Hywel Williams) also mentioned discussions with the devolved nations, and I am very happy to have discussions with my counterparts in the devolved health authorities.

As we have heard from my hon. Friend the Member for Harrow East and others, many in this room are supportive of a “polluter pays” levy. As they will be aware, tobacco taxation is a matter for Her Majesty’s Treasury, and the tobacco industry is already required to make a significant contribution to public finances through tobacco duty, VAT and corporation tax. As part of the development of the tobacco control plan, the Department will also continue to explore and review with the Treasury the evidence base on the best options to raise funding in support of the Government’s ambition to be smokefree by 2030. As a number of Members asked, I am happy to meet the APPG to discuss funding matters and the levy in detail, while the Khan report is being published. I have met the APPG before and am happy to continue having those meetings.

Civil Proceedings

Debate between Maggie Throup and Jim Shannon

Tuesday 29th March 2022 Commons Chamber

[Maggie Throup]

The right hon. Gentleman makes a very good point. We know that the pandemic has had a mental health impact not just on children and young people, but on people of all ages. That is why it is important that we are now living with covid and getting our lives back to normal, which is one way of helping restore that normality that we are so desperate to get back to.

The Government helped businesses at a time when many faced disruption, including through the coronavirus job retention scheme. We have also supported the self-employment income support scheme, which paid out more than £28 billion to nearly 3 million self-employed people and was one of the most generous schemes for the self-employed in the world.

[Jim Shannon (Strangford) (DUP)]

The legislation covers England, Wales and Northern Ireland. Will the Minister reassure me that full consultation has taken place with the Health Minister and the Economy Minister in Northern Ireland to ensure that what she is mentioning is endorsed by the Northern Ireland Assembly?

[Maggie Throup]

I shall come shortly to the specific parts of the extension that are relevant to Northern Ireland. I am sure that the hon. Gentleman will appreciate that we have had ongoing conversations with the devolved Administrations throughout the whole two years.

The Coronavirus Act 2020 also helped to ease the burden on frontline staff in our critical public services. For example, provisions in the Act have helped the courts and tribunal system to keep functioning throughout the pandemic by allowing thousands of hearings to take place remotely.

Health Inequalities: Office for Health Improvement and Disparities

Debate between Maggie Throup and Jim Shannon

Wednesday 26th January 2022 Westminster Hall

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

It is a pleasure to serve under your chairmanship, Mr Twigg. I congratulate the hon. Member for Bootle (Peter Dowd) on bringing forward this extremely important debate. It has been really interesting and, with many people contributing, it has been quite rounded. The hon. Gentleman spoke passionately and knowledgeably about the issue, as did other Members. We have probably done the issue a disservice by having only an hour and a half to debate it. I look forward to further debates.

It is time to shift the centre of gravity of the health system from treating disease to building good health. To do that, we have to focus on the people and places who face the worst health outcomes. That is why on 1 October 2021, we launched the Office for Health Improvement and Disparities. The mission of OHID is to improve the health of our country so that everyone can expect to live longer in good health, and to break the link between people’s background and their prospects for a healthy life.

OHID is doing that by working with the rest of Government, the healthcare system, local government and industry, to bring together expert advice, analysis and evidence in policy development and implementation. As a number of hon. Members mentioned, covid has shone a light on the poor underlying health of certain groups in the population, the depth of health disparities and the implications for our health, economy and society.

Health disparities across the UK are stark. As the hon. Member for Bootle highlighted, in the borough of Sefton, where his constituency is located, the life expectancy deprivation gap is 11.8 years for women and 12.5 years for men. Health disparities can be driven by a range of factors, including education, income, employment and early years experiences. Therefore, OHID aims to systematically tackle the top preventable risk factors for poor health by looking actively at the evidence on health disparities and the ways in which we can go further to address them.

The new Health Promotion Taskforce, which was set up by the Prime Minister, will drive and support the whole of Government to go further in improving health and reducing disparities, because many of the factors most critical to good physical and mental health are the responsibility of partners beyond the health service. This new Cabinet Committee, now chaired by the Secretary of State for Health and Social Care, brings Departments together around the objective of reducing ill health and health disparities. It also provides a new opportunity to work together actively on the most important health issues and agree new ways to address them collectively. I hope that helps reassure colleagues that the new taskforce is at the top of Government, and is determined to bring all Departments together to tackle this agenda.

[Jim Shannon]

In my contribution, I referred to the contact that I have had with Crisis on homelessness. Will the contact that the Minister has referred to include those groups? They have the facts. She will have heard what I said about the disparities between those who, like us, live in a well-off area, and those who do not and have not got a home. Homelessness is deadly.

[Maggie Throup]

I reassure the hon. Gentleman that tackling homelessness is a high priority for this Government.

As hon. Members have mentioned, the Government will shortly publish a landmark levelling-up White Paper that will set out bold new policy interventions to improve livelihoods and opportunities in all parts of the UK, and to reduce the disparities between different parts of the UK. Poor health is stopping people accessing quality education and jobs with good career prospects, limiting their career progress, and undermining local prosperity and the general wellbeing of communities across the UK. Of course, it would be wrong of me to pre-announce the contents of that important White Paper.

Tackling health disparities promotes economic prosperity by increasing productivity and reducing strain on public services, including the economic cost of preventable ill health to the NHS and the welfare system. To address those issues, we are investing in tackling the key contributors, such as obesity and smoking. We are also investing £500 million to transform Start4Life and family health services.

Oral Answers to Questions

Debate between Maggie Throup and Jim Shannon

Tuesday 18th January 2022 Commons Chamber

[Maggie Throup]

My hon. Friend makes a good point. The most vulnerable people are being prioritised. The UK Health Security Agency and NHS Test and Trace currently deliver an average of more than 70,000 PCR kits and 970,000 LFD kits a week to adult social care settings. In recent weeks, as demand has increased due to the omicron wave, Dudley, like other local authorities, has provided tests to key workers to enable them to keep working.

[Jim Shannon (Strangford) (DUP)]

I thank the Minister for her response. The Government have recently announced that self-isolation will be cut to five days, given a negative lateral flow test. Has the Minister come to an assessment on the impact that will have on demand for lateral flow tests, given the struggle many have faced trying to obtain a box of them in recent weeks?

[Maggie Throup]

As we look at policy and amend it like we did last week, it is right that we make sure that we can fill those requirements. I reassure the hon. Gentleman that we can, and we have increased the procurement of lateral flow devices. This month, we will get another 750 million lateral flow devices into the UK for January and February.

Vaccination Strategy

Debate between Maggie Throup and Jim Shannon

Wednesday 12th January 2022 Commons Chamber

[Maggie Throup]

Those who are clinically extremely vulnerable or immunosuppressed have already been offered a booster, so they have already received four doses. As I said earlier, at the end of last week the JCVI determined that at this stage it was not appropriate for others to have a booster or a fourth dose.

[Jim Shannon (Strangford) (DUP)]

The Titanic Exhibition Centre, which is the largest vaccination centre in Northern Ireland, is to close on Sunday 16 January. Has the Minister made an assessment, in her Department, of the impact that the closure of mass vaccination centres will have on the booster process throughout the United Kingdom of Great Britain and Northern Ireland?

[Maggie Throup]

As I understand it, the location of vaccination sites in the devolved nations is the responsibility of those nations. I can only speak for England in that regard, so the hon. Gentleman may wish to take the matter up with the Minister of Health in Northern Ireland.

Public Health

Debate between Maggie Throup and Jim Shannon

Tuesday 30th November 2021 Commons Chamber

[Maggie Throup]

I reiterate that I cannot speak for other people. I am setting out the measures today that we implemented this morning in a timely fashion, and it is those measures that we are considering. From the Government’s point of view, that is the legislation that we are implementing.

[Jim Shannon (Strangford) (DUP)]

I support what the Minister is putting forward. What happens here will happen in Northern Ireland, as the Minister in Northern Ireland has said that he will follow the instructions and guidelines from Westminster. We are aware of the variant and we are aware at this stage that our vaccinations may be enough to combat it. If we hand wash, distance and wear a mark, surely we cannot do anything other than support the measure. Does she agree that other hon. Members should adopt the same attitude?

[Maggie Throup]

I speak for myself in saying that I have changed my habits with regard to hand washing since the pandemic began, much to the detriment of my skin. We can take simple measures that have been put in place that have no impact on other people but help to protect us and others indirectly.

UK Vaccination Strategy

Debate between Maggie Throup and Jim Shannon

Monday 8th November 2021 Commons Chamber

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

I thank my hon. Friend the Member for Mole Valley (Sir Paul Beresford) for bringing this important debate to the House and for his kind words about the success of the covid-19 vaccination programme. He speaks with a great deal of knowledge and personal experience, and I thank him for that.

I am going to talk about the covid vaccination programme as a great example of how well the UK has done in putting together a programme in a short time with great success, which I know my hon. Friend will want us to emulate in other areas. Our phenomenal covid vaccination programme continues at pace, with almost nine in 10 people aged 12 and over having now received at least one dose and more than 10 million people throughout the UK having had their booster and third vaccination dose.

[Jim Shannon (Strangford) (DUP)]

I spoke to the hon. Member for Mole Valley (Sir Paul Beresford) and he suggested that I should ask the Minister this question. Those over 50 with a vulnerable disease or who are on a priority list have been told that they can get the booster vaccine; if someone happens to be aged 40 or 35 and is a type 1 diabetic in a vulnerable position, should they not also get the booster injection as a priority?

[Maggie Throup]

The criteria for who should receive a third dose are set by the Joint Committee on Vaccination and Immunisation. We take its recommendations and roll things out according to that advice.

I thank each and every person who has come forward for their jab, as well as the tens of thousands of NHS staff and volunteers who have made this happen. Vaccines remain our biggest line of defence as we head into a challenging winter period. Vaccinated people are less likely to get seriously ill with covid-19, to be admitted to hospital or to die from it. There is also evidence that they are less likely to pass the virus on to others. Although the vaccine efficacy against severe disease remains high, we know that a small change can generate a major shift in hospital admissions—for example, a change in efficacy from 95% to 90% would lead to the doubling of hospital admissions among those vaccinated.

Early results from Pfizer show that a booster jab restores protection to 95.6% against symptomatic infection. That is why we have launched the booster programme—to top up the immunity for those at increased risk of complications from covid-19 over the winter months, helping to keep people out of hospital, to reduce pressure on our NHS, and, as my hon. Friend has indicated, to ensure that there are fewer patients with covid-19 in need of an expensive hospital bed. The UK already has one of the highest covid-19 vaccine uptake rates in the world and we are working closely with the NHS to make it as easy as possible for everyone to get a vaccine.

There are more than 2,200 vaccination sites in operation across the country, an additional 500 extra vaccination sites now compared with April this year. Hundreds of walk-in sites across the country are now also offering booster vaccines, making it even easier for people who are eligible to get their top-up jab. From Elland Road in Leeds to the Kassam Stadium in Oxford, the NHS is making it as easy as possible for people to get vital protection against the virus ahead of the winter months.

We are working with the NHS to provide advice and information at every opportunity on how to get a vaccine and its benefits as well as combating any misinformation. The NHS is engaging every single day with local authorities, faith leaders and organisations representing ethnic minority communities to provide advice and information about vaccines and about how they will be made available.

Our communications include information and advice via TV, radio and social media, and this has been translated into more than 13 different languages. Print and online material, including interviews and practical advice, has appeared in 600 national, regional, local and specialist titles. We have worked with clinicians and medical influencers to communicate the benefits of the vaccine and deliver content via the media and social media platforms.

This is just some of the huge amount of activity that has taken place, and that continues to take place, to ensure that as many people as possible can benefit from the vaccine, but we are not resting on our laurels. We have been continually learning throughout the roll-out of the vaccine. We look at research from trusted and reputable sources and we have identified some of the most effective interventions. I am sure that we can learn from this for other vaccination programmes, too. For example, we have learned that engagement with local communities, targeting specific gaps in vaccine uptake and getting local, trusted community leaders involved—people who know their communities well—is a very effective approach.

There are countless, brilliant examples of local activity around the country, but I shall mention Salford where they worked specifically with people experiencing homelessness, and were able to vaccinate 653 people. Every jab helps to save lives, and these are some of the hardest to reach people in our society, and also those who would have been most vulnerable to the virus. We have also increased the amount of information publicly available on vaccines, including more transparency about its benefits, safety, and potential side effects.

I can fully assure my hon. Friend that this Government are committed to tackling covid-19 vaccine misinformation, and I agree with every word that he has said so passionately on this: vaccine misinformation is dangerous and costs lives. That is why we stood up the cross-Whitehall counter-disinformation unit, specifically to tackle online misinformation and disinformation, and to hold social media companies to their public commitments to combat covid misinformation. We have also produced a wide variety of communications and toolkits to share case stories, build confidence, and provide trusted information about the safety of the vaccine.

Throughout the pandemic, the Government have been guided by the advice of the Joint Committee on Vaccination and Immunisation and the four UK chief medical officers, and we have consulted a wide range of experts and ensured that their advice is embraced and actioned. Trusted experts such as our deputy chief medical officer Jonathan Van-Tam and so many others have all helped to build confidence in the vaccine in our communities where uptake is traditionally low. That has made a big difference. YouGov polling indicates that vaccine hesitancy in ethnic minority groups reduced from 63% to 14% from October 2020 to August 2021.

I can assure my hon. Friend that we do not have an ounce of complacency, and will continue to do whatever we can to stamp out dangerous misinformation. He is keen that we translate the successes of the covid vaccination programme into all our immunisation programmes. I fully agree that there is so much learning from our response to the pandemic that can inform and strengthen our wider vaccination programme.

The UK already has world-leading childhood immunisation programmes, and vaccine coverage from most of our childhood programmes is generally high. My hon. Friend was quite correct when he indicated that uptake had fallen slightly due to school closures and social distancing. I reassure him that the mitigation measures are in place to ensure that no child misses out on those vaccinations. However, we know that uptake rates must improve to fully protect the public from preventable diseases. We made a manifesto commitment to maintain and improve the routine childhood vaccination programme, and we recognise that there is still more that can be done to improve uptake in all programmes.

The publication of England’s national vaccine strategy has been delayed as a result of our ongoing focus on responding to the unprecedented covid-19 pandemic, but rest assured the strategy has been kept under constant review and is in the process of being refreshed to reflect the changed landscape that the pandemic has brought, including new developments from the covid-19 vaccine and the extended NHS flu programme.

I know that my hon. Friend has a particular interest in the use of data and technology. Both offer immense benefits to every individual who seeks vaccination and to the health system that supports them. Our ambition is to make vaccination records easily available digitally so that each individual, and anyone treating them, can easily access their vaccination records, know which vaccines they have had, which they still need, and when they are due to receive them. The covid-19 pandemic has reinforced both the importance of vaccines—as they offer the best way out of the pandemic and the return to normal life—and our certainty that we can do even better and create even stronger, more effective vaccination programmes in the future.

Flu is another winter virus that can be serious, especially when combined with covid-19. That is why we are running the largest ever flu vaccination programme in UK history. A record 35 million people in England can book a free flu jab this year—the most ambitious effort ever to protect individuals and their loved ones from what can be a very nasty illness. It is vital that we build on the learning from the successes of the covid-19 vaccine programme, and use it to improve all vaccine programmes.

The covid-19 vaccine roll-out continues to be a success through every single vaccine given. I ask those people who peddle untruths and misinformation about the benefits of the vaccine to look at the evidence: more than 130,000 lives saved; and more than 24 million infections and 230,000 hospitalisations prevented. The facts are clear. That is 130,000 families who continue to have a mother, father, husband, wife, daughter, son, brother or sister still with them—and that is powerful. It is for that reason that we will continue to tackle vaccine misinformation head-on, and to promote the benefits of the vaccine to as many people as possible.

Finally, and as I have been grateful to have the opportunity to say many times at this Dispatch Box over the last few weeks, I urge everyone to get their booster jab as soon as they are eligible. To those who have not had their first jab yet: it is never too late.

Question put and agreed to.

Covid-19: Government Response

Debate between Maggie Throup and Jim Shannon

Thursday 21st October 2021 Commons Chamber

[Jim Shannon (Strangford) (DUP)]

I wish the Minister well in her new role. Will she outline what plans are in place to begin to get on top of waiting lists, for example on breast reconstruction post mastectomy, hip replacements and tonsil operations? Will additional funding be made available to outsource work to private hospitals to reduce waiting lists and to give people back their health, mobility and confidence?

[Maggie Throup]

I thank the hon. Gentleman for his question. I reassure him that a lot of investment is being put into the health service, as I am sure he is aware, to ensure that we can tackle the backlog that has been created because of the pandemic.

Covid-19 Update

Debate between Maggie Throup and Jim Shannon

Thursday 21st October 2021 Commons Chamber

[Jim Shannon (Strangford) (DUP)]

The Government’s vaccine roll-out has been a success story, but it is important that we continue that success story. I had the flu jab three weeks ago and I will have my covid booster in about four weeks. All sorts of constituents have contacted me to ask why they have been called for a third primary dose of the vaccine along with their flu jab. Are the Government considering a wider publicity campaign to clarify the reason behind the third jab, the criteria for the booster and the need for the flu jab as well at the same time?

[Maggie Throup]

A communications programme has been rolled out this week to encourage people to get their booster and their flu jab, and to get whichever comes first and then the other as soon as it is available.

Budget Resolutions

Debate between Maggie Throup and Jim Shannon

Monday 27th November 2017 Commons Chamber

[Maggie Throup (Erewash) (Con)]

I am pleased to be able to contribute to tonight’s debate on the Budget. I want to highlight three main areas: the support for electric vehicles; the additional funding for STPs—sustainability and transformation partnerships—and the NHS; and the funding for HS2 infrastructure.

First, I welcome the Government’s ambition for the UK to be world leader in electric cars, thus contributing so cleverly to the global Britain. It is a great ambition. However, a local independent garage owner in my constituency, Jonathan Wright, shared with me the level of concern that he is hearing from other garage owners about the cost of retraining their mechanics in the new technology of hybrids. I ask the Minister to consider what measures could be put in place to plug the black hole in hybrid technology training, not just for the new apprentices coming through but for the existing workforce who are going to be so crucial if we are to move forward at the rate that we expect with new technology for our vehicles.

[Jim Shannon (Strangford) (DUP)]

Will the hon. Lady give way?

[Maggie Throup]

No, because I am short of time.

Secondly, on health and social care, I, like other Conservative Members, welcome the £2.8 billion of additional resource funding for the NHS in England. I was saddened by the comments of the hon. Members for City of Durham (Dr Blackman-Woods) and for Chesterfield (Toby Perkins), who are no longer in their places, and the hon. Member for York Central (Rachael Maskell), who still is. I ask them to read the Chancellor’s speech, because he committed £2.6 billion to sustainability and transformation partnerships—programmes that help people to stay in their own homes and in the community, and try to keep them out of hospital. That, to me, is social care. Just because we have not labelled it as social care does not mean that it is not social care. I am delighted that the Chancellor took on board my submission for the additional STP funding. We can only make the desired switch from the acute setting to the community setting with the appropriate transitional funding. I am sure that the additional £2.6 billion of funding that has been allocated will be well spent. This principle of providing care in our communities makes me believe that Derbyshire County Council’s threat of closure of Hazelwood care home in Ilkeston in my constituency is completely wrong. Ill-thought-through actions such as closures of care homes threaten the viability of STPs and must not be allowed to happen. STPs are a crucial part of our future.

Thirdly, I want to touch on the £300 million support for infrastructure for HS2. Again, I am delighted that the Chancellor recognised my submission on this. Only by investing in more than just the train line itself will the true potential of HS2 be unlocked. I would appreciate more details on this funding. With Erewash and, in particular, Long Eaton, Sandiacre and Stanton Gate being dramatically impacted by HS2, I could spend the whole £300 million in Erewash alone, but I am sure that I will not be allowed to. My shopping list for this money is quite long. It includes acquiring land for business relocation, acquiring land for new homes where those made homeless by HS2 can be rehoused, a new motorway junction at junction 25A of the M1, and improving the existing road infrastructure to ensure that it can cope with the additional traffic that HS2 will undoubtedly bring to the area. I welcome the measures in the Budget and commend it to the House.

Dementia and Alzheimer’s Disease

Debate between Maggie Throup and Jim Shannon

Tuesday 12th April 2016 Westminster Hall

[Jim Shannon]

I was going to come to that issue. I thank the hon. Gentleman for that intervention. It is not just about the diagnosis of dementia and Alzheimer’s, but about the follow-up, the path of care and how we help the whole way through. I will touch on some of those things later in my speech.

We must not abandon or diminish our efforts to find a cure. We have to take into account the reality we face and carefully plan for the future, so that all those with dementia and Alzheimer’s can get the care and support they so desperately need. As the hon. Gentleman said, that is the issue we have to address.

[Maggie Throup (Erewash) (Con)]

We are talking about end-of-life support, but we have to take a practical approach. One of the charities in my constituency—Community Concern Erewash—has a project to dementia-proof houses in Erewash to help people in the early stages of dementia stay in their houses for longer. They are doing things such as labelling drawers and rooms, so that people know exactly know where they are and can navigate their house for longer. Does the hon. Gentleman agree that such practical measures will make a difference?

[Jim Shannon]

The hon. Lady is absolutely right. The simplest things can make a difference. It is about improving quality of life and letting people with dementia and Alzheimer’s have a life with their families.

--- Later in debate ---

[Jim Shannon]

The hon. Gentleman has clearly hit on a very salient point.

In relation to the science and medical sectors, I ask the Minister about the significant spend on and moneys set aside for the investigation into how dementia happens, which the hon. Member for Beckenham (Bob Stewart) asked about in his intervention. That money will help to find a cure—and we need to find a cure, because we have to give hope. To give hope, we have to have medical interventions and the investigations leading to them.

[Maggie Throup]

The hon. Gentleman is talking about a cure. Recently, I visited the department of human genetics at the University of Nottingham, which is working hard on a genomics project to identify the change in the genes that might cause dementia and Alzheimer’s, so there is light at the end of the tunnel, although it is a long way off. Great work is being carried out, however, not only in Nottingham, but in many places in the UK and throughout the world.

[Jim Shannon]

We have to encourage all medical advances.

The number of people living with the condition in the UK is revealed as more startling when we take into account the unsung heroes—the carers.

Antibiotics (Primary Care)

Debate between Maggie Throup and Jim Shannon

Monday 23rd November 2015 Commons Chamber

[Maggie Throup (Erewash) (Con)]

First, I would like to declare an interest. Over 20 years ago, I was responsible for trying to launch a C-reactive protein point-of-care test, along with other point-of-care tests. The timing and circumstances were not right then, but things have moved on, and I believe the time is now right to get C-reactive protein point-of-care testing established in the primary care setting.

Last Monday was world antimicrobial day and that, along with the extensive media coverage over recent days about antimicrobial resistance and the vast difference between summer and winter antibiotic prescribing, makes this is a very timely debate. Antibiotics have been widely used to treat infections for more than 60 years, and without doubt the use of antibiotics has saved many millions of lives. I doubt if there is any right hon. or hon. Member who has never taken an antibiotic at some time in their life, but such extensive use of antibiotics has now become a real issue and a ticking timebomb.

Although new infectious diseases have been discovered nearly every year during the past 30 years, very few new antibiotics have been developed in that time, meaning that existing antibiotics are used to treat more and more infections. The consequence has been an increase in the prevalence of resistance to antibiotics, which in turn puts our ability to treat routine diseases in serious jeopardy. At present, treatment-resistant bacteria are responsible for approximately 25,000 deaths across Europe each year, which is a similar number to those dying in road accidents. The national risk register of civil emergencies has estimated that a widespread outbreak of a bacterial blood infection could affect 200,000 people in the UK. If it could not be treated effectively with our existing drugs, approximately 40% of those affected might die as a result, which is 80,000 people. There is an urgent need for action to slow the spread of antimicrobial resistance.

For a number of years, there has been a clear consensus among clinicians, academics and policy makers that antimicrobial resistance represents a major current and future danger to the foundations of modern medicine. In recognition of that danger, tackling the threat of antimicrobial resistance has been identified as a key priority by the Government, Public Health England and the chief medical officer. Just two years ago, the chief medical officer described the threat of antimicrobial resistance as

“just as important and deadly as climate change and international terrorism.”

I wish to focus on antibiotics in primary care and what measures can be taken to have a real impact on the way in which they are prescribed, which is currently almost like handing out a bag of sweets at the fair. In fact, 97% of patients who ask for antibiotics are prescribed them, whether or not they should have them. Owing to the popularity of primary care in the UK, that setting represents the part of the healthcare system where antibiotics are most likely to be prescribed, with 74% of them prescribed in that setting. International comparisons show that antibiotic resistance rates are strongly related to antibiotic use in primary care.

Despite guidance encouraging a reduction in antibiotic prescribing rates, nine out of 10 GPs say that they feel pressured into prescribing antibiotics. In the UK, we do like taking antibiotics. In 2013, data showed that 41% of residents had taken antibiotics in the previous 12 months, compared with a European average of 35%. Nationally, in 2013-14—the most recent year for which I have managed to get hold of the data—a staggering 41.6 million antibiotic prescriptions were issued, at a cost of £192 million to the NHS.

[Jim Shannon (Strangford) (DUP)]

I congratulate the hon. Lady on securing the Adjournment debate. She has outlined the issues and the epidemic potential among those who do not respond to antibiotics. Does she agree that we need something focused not just on England and Wales, but on the whole of the United Kingdom of Great Britain and Northern Ireland because this strategy has to help us all? In her submission to the House, will she say—perhaps the Minister could respond along the same lines—whether we should have a UK-wide strategy to address the issue for the constituents of all Members of the House and further afield?

[Maggie Throup]

I completely agree with the hon. Gentleman. It is not just a UK-wide issue; it affects the whole world. That is one of my concerns. We need to play our part to set the trend for the whole world, because this is a global issue.

As I said, antibiotic prescriptions in 2013-14 cost the NHS £192 million. What is more worrying is that many of the 41.6 million prescriptions were unnecessary and will undoubtedly have contributed to the growing issue of antimicrobial resistance. More than half the antibiotics used in primary care are for respiratory tract infections, most of which are viral or self-limiting.

So what can be done to halt the ticking timebomb? Just last Wednesday, Public Health England called for NHS patients to become “antibiotic guardians” by thinking carefully before asking for drugs and taking more care to prevent the spread of infections by washing their hands and accepting the flu jab. I believe that we can go even further in reducing the use of antibiotics in ways that are better for the patient and that save the NHS money.